Thus, VEGF‐Ahyper mice are a clinically representative animal model that allows us to assess the effects of a pathophysiologically relevant increase in VEGF‐A for the manifestation of aging eye diseases, such as AMD. This evidence concerns the gene VEGFA and age-related macular degeneration.